<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11861101</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.198</article-id><article-id pub-id-type="other">O0072</article-id><article-id pub-id-type="pii">S0924933824001986</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>Oral Communication</subject></subj-group></article-categories><title-group><article-title>A Meta-Analysis of fMRI Activation Studies of Ketamine in Healthy Participants</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Shepherd</surname><given-names>J. H.</given-names></name><xref rid="aff0257" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor0059" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hickman</surname><given-names>A.</given-names></name><xref rid="aff0257" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Baten</surname><given-names>C.</given-names></name><xref rid="aff0257" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Klassen</surname><given-names>A. M.</given-names></name><xref rid="aff0257" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zamora</surname><given-names>G.</given-names></name><xref rid="aff0257" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Johnson-Venegas</surname><given-names>E.</given-names></name><xref rid="aff0257" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Madugula</surname><given-names>S. S.</given-names></name><xref rid="aff0258" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Woo</surname><given-names>E.</given-names></name><xref rid="aff0257" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Miller</surname><given-names>J. A.</given-names></name><xref rid="aff0259" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sacchet</surname><given-names>M. D.</given-names></name><xref rid="aff0260" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hedges</surname><given-names>D. W.</given-names></name><xref rid="aff0261" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Miller</surname><given-names>C. H.</given-names></name><xref rid="aff0257" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff0257">
<sup>1</sup>Department of Psychology, <institution>California State University</institution>, <city>Fresno</city>, <country>Fresno</country></aff><aff id="aff0258">
<sup>2</sup>School of Medicine, <institution>Stanford University</institution>, <city>Stanford</city></aff><aff id="aff0259">
<sup>3</sup>Department of Psychology, <institution>Palo Alto University</institution>, <city>Palo Alto</city></aff><aff id="aff0260">
<sup>4</sup>Department of Psychiatry, Massachusetts General Hospital, <institution>Harvard Medical School</institution>, <city>Boston</city></aff><aff id="aff0261">
<sup>5</sup>Department of Psychology, <institution>Brigham Young University</institution>, Provo, <city>Provo</city>, <country>United States</country></aff><author-notes><corresp id="cor0059"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="173">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S74</fpage><lpage>S74</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824001986a.pdf"/><abstract><sec id="sec0351"><title>Introduction</title><p>There has been rapidly growing interest in understanding the pharmaceutical and clinical properties of psychedelic and dissociative drugs, with a particular focus on ketamine. This compound, long known for its anesthetic and dissociative properties, has garnered attention due to its potential to rapidly alleviate symptoms of depression, especially in individuals with treatment-resistant depression (TRD) or acute suicidal ideation or behavior. However, while ketamine&#x02019;s psychopharmacological effects are increasingly well-documented, the specific patterns of its neural impact remain a subject of exploration and basic questions remain about its effects on functional activation in both clinical and healthy populations.</p></sec><sec id="sec0352"><title>Objectives</title><p>This meta-analysis seeks to contribute to the evolving landscape of neuroscience research on dissociative drugs such as ketamine by comprehensively examining the effects of acute ketamine administration on neural activation, as measured by functional magnetic resonance imaging (fMRI), in healthy participants.</p></sec><sec id="sec0353"><title>Methods</title><p>We conducted a meta-analysis of existing fMRI activation studies of ketamine using multilevel kernel density analysis (MKDA). Following a comprehensive PubMed search, we quantitatively synthesized all published primary fMRI whole-brain activation studies of the effects of ketamine in healthy subjects with no overlapping samples (N=18). This approach also incorporated ensemble thresholding (&#x003b1;=0.05-0.0001) to minimize cluster-size detection bias and Monte Carlo simulations to correct for multiple comparisons.</p></sec><sec id="sec0354"><title>Results</title><p>Our meta-analysis revealed statistically significant (p&#x0003c;0.05-0.0001; FWE-corrected) alterations in neural activation in multiple cortical and subcortical regions following the administration of ketamine to healthy participants (N=306).</p></sec><sec id="sec0355"><title>Conclusions</title><p>These results offer valuable insights into the functional neuroanatomical effects caused by acute ketamine administration. These findings may also inform development of therapeutic applications of ketamine for various psychiatric and neurological conditions. Future studies should investigate the neural effects of ketamine administration, including both short-term and long-term effects, in clinical populations and their relation to clinical and functional improvements.</p></sec><sec id="sec0356"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>